Watch CNMD. Know when insiders buy.
One email the day a filing lands. Free.
CNMD
CONMED Corp
46.22
−0.71 −1.51%
USD · close Sep 10
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
41
WATCH · shorts 41
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.4BP/E 30.6DIV YIELD 1.30%FCF YIELD 10.90%REV TTM $1.4B +5.2%NET INCOME $47.1M −64.5%NET DEBT $768.3M52W 32.11 – 54.05SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $343.5M | +6.9% | 57.5% | $36.4M | $23.1M | +282.2% | 0.77 | — | — | — | Jul 29 |
| Q4 2025 · Dec 31derived | $373.2M | +7.9% | 58.5% | $36.6M | $16.7M | −50.4% | 0.54 | $46.3M | $5.1M | $41.2M | Feb 17 |
| Q3 2025 · Sep 30 | $337.9M | +6.7% | 49.2% | $11.9M | $2.9M | −94.2% | 0.09 | $53.7M | $5.2M | $48.5M | Nov 6 |
| Q2 2025 · Jun 30 | $342.3M | +3.1% | 55.0% | $38.2M | $21.4M | −28.5% | 0.69 | $29.1M | $5.7M | $23.4M | Jul 29 |
| Q1 2025 · Mar 31 | $321.3M | +2.9% | 55.3% | $16M | $6M | −69.4% | 0.19 | $41.5M | $3.8M | $37.8M | Jul 29 |
| Q4 2024 · Dec 31derived | $345.9M | +5.8% | 57.3% | $52.5M | $33.8M | +2.1% | 1.08 | $43.3M | $4M | $39.3M | Feb 17 |
| Q3 2024 · Sep 30 | $316.7M | +4.0% | 56.5% | $65.7M | $49M | +209.3% | 1.57 | $51.2M | $3.4M | $47.8M | Nov 6 |
| Q2 2024 · Jun 30 | $332.1M | +4.5% | 55.3% | $47.1M | $30M | +118.3% | 0.96 | $43.3M | $3.6M | $39.7M | Nov 6 |
| Q1 2024 · Mar 31 | $312.3M | — | 55.1% | $35M | $19.7M | — | 0.63 | $29.1M | $2M | $27.1M | Nov 6 |
| Q4 2023 · Dec 31derived | $327M | — | 55.7% | $50.2M | $33.1M | — | 1.05 | $56.4M | $4.9M | $51.5M | Feb 17 |
| Q3 2023 · Sep 30 | $304.6M | — | 55.2% | $30.3M | $15.8M | — | 0.50 | $46.1M | $5.4M | $40.7M | Oct 31 |
| Q2 2023 · Jun 30 | $317.7M | — | 53.7% | $27.4M | $13.7M | — | 0.43 | $26.7M | $4.5M | $22.1M | Oct 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.4B | 54.6% | $102.6M | $47.1M | 3.4% | 1.51 | $170.7M | $19.8M | $150.9M | — | $24.7M |
| FY2024 · to Dec 31 | $1.3B | 56.1% | $200.3M | $132.4M | 10.1% | 4.25 | $167M | $13.1M | $153.9M | — | $24.7M |
| FY2023 · to Dec 31 | $1.2B | 54.3% | $120.6M | $64.5M | 5.2% | 2.04 | $125.3M | $19M | $106.3M | — | $24.5M |
| FY2022 · to Dec 31 | $1B | 54.6% | $70.1M | −$80.6M | -7.7% | -2.68 | $33.4M | $21.8M | $11.6M | — | $24M |
| FY2021 · to Dec 31 | $1B | 56.2% | $109.7M | $62.5M | 6.2% | 1.94 | $111.8M | $14.9M | $96.9M | — | $23.3M |
| FY2020 · to Dec 31 | $862.5M | 53.4% | $46M | $9.5M | 1.1% | 0.32 | $64.5M | $13M | $51.5M | — | $22.8M |
Every number comes from CONMED Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.